Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Aug 14;16:3437–3454. doi: 10.2147/JIR.S421491

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 Liu et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Kaplan–Meier survival analysis. (A). Patients with a high SIRI value (SIRI ≥ 4.15) had a much higher mortality rate at long-term follow-up than patients with a low SIRI value (SIRI < 4.15); (B). Patients with a high SIRI value (SIRI ≥ 4.15) had a much higher new-onset nonfatal acute myocardial infarction (AMI) rate at long-term follow-up than patients with a low SIRI value (SIRI < 4.15); (C). Patients with a high SIRI value (SIRI ≥ 4.15) had a much higher congestive heart failure (HF) rate at long-term follow-up than patients with a low SIRI value (SIRI < 4.15); (D). Patients with a high SIRI value (SIRI ≥ 4.15) had a much higher revascularization in unstable angina (UA) rate at long-term follow-up than patients with a low SIRI value (SIRI < 4.15); (E). Patients with a high PIV (PIV ≥ 622.71) had a much higher mortality rate at long-term follow-up than patients with a low PIV (PIV < 622.71); (F). Patients with a high PIV (PIV ≥ 622.71) had a much higher new-onset nonfatal acute myocardial infarction (AMI) rate at long-term follow-up than patients with a low PIV (PIV < 622.71); (G). Patients with a high PIV (PIV ≥ 622.71) had a much higher congestive heart failure (HF) rate at long-term follow-up than patients with a low PIV (PIV < 622.71); (H). Patients with a high PIV (PIV ≥ 622.71) had much a higher revascularization in unstable angina (UA) rate at long-term follow-up than patients with a low PIV (PIV < 622.71).

Abbreviations: SIRI, systemic inflammation response index; PIV, pan-immune-inflammation value.